Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2044

Annual patent cliff calendar for 2044 — US pharmaceutical patents by expiration date.

Patents
1,766

Quick answer

1,766 indexed pharmaceutical patents have expiration dates in 2044. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 11939365

    T cell receptors recognizing mutated P53

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11939345

    Physiologically stable fluorophore and performing fluorescence probing

    Government of the United States of America, as represented by the Secretary of Commerce · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11939343

    Sting agonist compounds and methods of use

    Mersana Therapeutics, Inc. · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11939327

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11939317

    Amide compounds and method for making and using

    Rigel Pharmaceuticals, Inc. · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11939346

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11939301

    5HT1F receptor agonists and mitochondrial biogenesis

    United States Government as represented by the Department of Veterans Affairs · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11938227

    Lipid nanoparticles encapsulation of large RNA

    ARCTURUS THERAPEUTICS, INC. · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11938221

    Multivalent nanoparticle-based vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11939297

    Cannabinoid receptor mediating compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11938233

    1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof

    UNIVERSITÄTSKLINIKUM REGENSBURG · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11938182

    Halogenated xanthenes as vaccine adjuvants

    Provectus Pharmatech, Inc. · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11938177

    Peptide vaccine formulations and use thereof for inducing an immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11938174

    Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders

    Takeda Pharmaceutical Company Limited · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11938148

    Treatment of neurodegenerative disease with sodium chlorite

    The Regents of the University of California · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11938147

    Treatment of neurodegenerative disease with sodium chlorite

    The Regents of the University of California · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11938134

    Metalloenzyme inhibitor compounds

    Eikonizo Therapeutics, Inc. · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11938124

    Combination therapy for treatment of cancer

    PMV PHARMACEUTICALS, INC. · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11938149

    Treatment of neurodegenerative disease with sodium chlorite

    The Regents of the University of California · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. WO 2024064327

    OLIGOSACCHARIDES DE LAIT HUMAIN POUR AMÉLIORER LA FONCTION DE BARRIÈRE HÉMATO-ENCÉPHALIQUE

    ABBOTT LAB [US] · Granted Thu Mar 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. CA 3263063

    VELUSETRAG DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE LA PSEUDO-OBSTRUCTION INTESTINALE CHRONIQUE (POIC)

    ALFASIGMA SPA [IT] · Granted Thu Mar 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11945830

    Antiviral heterocyclic compounds

    Enanta Pharmaceuticals, Inc. · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11945872

    Anti-ACVR1 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11945824

    Heterocyclic compounds as anti-viral agents

    Enanta Pharmaceuticals, Inc. · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11944666

    Treatment of inflammatory conditions delivery of interleukin-1 receptor antagonist fusion protein

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11945778

    C4-carbonothioate-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11944687

    Carbohydrate conjugate RNA agents and process for their preparation

    Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11944532

    Engineered tendon graft for rotator cuff repair

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11944679

    Genome-wide identification of immune evasion functions in a virus

    The Regents of the University of California · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11945822

    Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor of cyclin dependent kinase

    Lead Discovery Center GmbH · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11944618

    Subcutaneous delivery of polymer conjugates of therapeutic agents

    Serina Therapeutics, Inc. · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11944614

    Imidazo[4,5-c]pyridine compounds as LSD-1 inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11946065

    Transgene cassettes, AAV vectors, and AAV viral vectors for expression of human codon-optimized CSTB

    The Board of Regents of the University of Texas System · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11944644

    T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11944626

    Small molecule inhibitors of ALDH and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11946049

    tRNA/pre-miRNA compositions and use in treating cancer

    The Regents of the University of California · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11945794

    Nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11945855

    Recombinant polypeptides comprising modified MHC class II DRa1 domains and methods of use

    United States Government as represented by the Department of Veterans Affairs · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11944683

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11945795

    Islet cell manufacturing compositions and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11945781

    Compounds for the treatment of acute and chronic kidney disease

    United States Government as represented by the Department of Veterans Affairs · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11944658

    Methods of heat inactivation of adenovirus

    Ultragenyx Pharmaceutical Inc. · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11944656

    Microbials for feed

    MICROBIAL DISCOVERY GROUP, LLC · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11944627

    Methods for treating hematological malignancies and Ewing's sarcoma

    Kura Oncology, Inc. · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11944617

    Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4

    Corcept Therapeutics Incorporated · Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. WO 2024068265

    PARTICULES DE TYPE VIRUS PRÉSENTANT DES ANTIGÈNES DU SARS-COV-2 UTILISÉES EN TANT QUE VACCINS DE RAPPEL ET LEURS UTILISATIONS

    BAVARIAN NORDIC AS [DK] · Granted Thu Apr 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11952364

    TRK inhibitors useful as anticancer drugs

    TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED · Granted Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11952365

    Anti-viral compounds

    Aligos Therapeutics, Inc. · Granted Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2044?

1,766 published patents in our USPTO index have expiration dates falling in calendar year 2044.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.